Shi Y - Search Results

1

Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation.

Li M, Ye W, Fu K, Zhou C, Shi Y, Huang W, Chen W, Hu J, Jiang Z, Zhou W. Li M, et al. Among authors: shi y. Eur J Med Chem. 2020 Sep 15;202:112509. doi: 10.1016/j.ejmech.2020.112509. Epub 2020 Jun 30. Eur J Med Chem. 2020. PMID: 32668379

2

Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.

Zhou L, Chen W, Cao C, Shi Y, Ye W, Hu J, Wang L, Zhou W. Zhou L, et al. Among authors: shi y. Eur J Med Chem. 2020 Mar 1;189:112028. doi: 10.1016/j.ejmech.2019.112028. Epub 2020 Jan 2. Eur J Med Chem. 2020. PMID: 31945665

3

Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.

Lv L, Liu C, Chen C, Yu X, Chen G, Shi Y, Qin F, Ou J, Qiu K, Li G. Lv L, et al. Among authors: shi y. Oncotarget. 2016 May 31;7(22):32184-99. doi: 10.18632/oncotarget.8607. Oncotarget. 2016. PMID: 27058756 Free PMC article.

4

Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.

Lv L, Shi Y, Wu J, Li G. Lv L, et al. Among authors: shi y. Int J Nanomedicine. 2021 Feb 23;16:1487-1508. doi: 10.2147/IJN.S282110. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33654398 Free PMC article. Review.

5

Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation.

Ou M, Deng Z, Shi Y, He J, Ye Z, Guo M, Cheng G, Wu J, Lv L. Ou M, et al. Among authors: shi y. Front Pharmacol. 2024 Nov 13;15:1496664. doi: 10.3389/fphar.2024.1496664. eCollection 2024. Front Pharmacol. 2024. PMID: 39605916 Free PMC article.

6

Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway.

Deng Z, Ou M, Shi Y, Li G, Lv L. Deng Z, et al. Among authors: shi y. Toxicol Appl Pharmacol. 2025 Jan;494:117158. doi: 10.1016/j.taap.2024.117158. Epub 2024 Nov 17. Toxicol Appl Pharmacol. 2025. PMID: 39561883

7

A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs.

Lv L, Shi Y, Deng Z, Xu J, Ye Z, He J, Chen G, Yu X, Wu J, Huang X, Li G. Lv L, et al. Among authors: shi y. Biomater Res. 2023 Dec 15;27(1):133. doi: 10.1186/s40824-023-00465-9. Biomater Res. 2023. PMID: 38102651 Free PMC article.

8

Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification.

Deng Z, Chen G, Shi Y, Lin Y, Ou J, Zhu H, Wu J, Li G, Lv L. Deng Z, et al. Among authors: shi y. Front Pharmacol. 2022 Aug 8;13:920514. doi: 10.3389/fphar.2022.920514. eCollection 2022. Front Pharmacol. 2022. PMID: 36003508 Free PMC article.

9

Sensitive Fluorescent Probe for Al³⁺, Cr³⁺ and Fe³⁺: Application in Real Water Samples and Logic Gate.

Lin Z, Shi Y, Song Y, Yan J, Li H, Xie C. Lin Z, et al. Among authors: shi y. J Fluoresc. 2025 Jan 11. doi: 10.1007/s10895-024-04130-9. Online ahead of print. J Fluoresc. 2025. PMID: 39798023

10

The molar dose of FAPI administered impacts on the FAP-targeted PET imaging and therapy in mouse syngeneic tumor models.

Liu L, Shi Y, He S, Yang J, Song S, Wang D, Wang Z, Zhou H, Deng X, Zou S, Zhu Y, Yu B, Zhu X. Liu L, et al. Among authors: shi y. Eur J Nucl Med Mol Imaging. 2025 Jan 11. doi: 10.1007/s00259-025-07071-y. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 39797968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,553 results

Search Page

Filters